Physician profile
Robin B Scheiner
NPI 1710063862
$2,429.43
in general payments reported to CMS, 2019-2025
24 companies · $451 in 2025
The $451 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.30 · 2020: $40.87 · 2021: $34.60 · 2022: $362 · 2023: $743 · 2024: $781 · 2025: $451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,976.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,975.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $426.56 | 2019-2025 | Rinvoq, Skyrizi |
| Lilly USA, LLC | $354.24 | 2022-2025 | Taltz, Olumiant, Ebglyss |
| Janssen Biotech, INC. | $188.17 | 2021-2025 | Tremfya, Simponi Aria, Simponi |
| Merz North America, INC. | $168.58 | 2024 | |
| Sun Pharmaceutical Industries INC. | $165.86 | 2022-2025 | Ilumya |
| Pfizer INC. | $155.43 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $146.30 | 2021-2024 | |
| Genzyme Corporation | $105.89 | 2022-2024 | |
| Galderma Laboratories, L.P. | $104.88 | 2022-2025 | Dysport, Aklief |
| E.R. Squibb & Sons, L.L.C. | $101.69 | 2023-2025 | Sotyktu |
| Regeneron Healthcare Solutions, INC. | $78.65 | 2022-2025 | Dupixent, Libtayo |
| Leo Pharma INC. | $69.81 | 2023-2024 | Adbry |
| Ucb, INC. | $54.71 | 2025 | Bimzelx |
| Dermavant Sciences, INC. | $46.34 | 2022-2024 | Vtama |
| Amgen INC. | $40.24 | 2023-2024 | Otezla |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $38.21 | 2022 | |
| Arcutis Biotherapeutics, INC. | $33.78 | 2023 | |
| Strata Skin Sciences, INC. | $27.85 | 2024 | Xtrac |
| Musculoskeletal Transplant Foundation INC. | $25.22 | 2024 | |
| Vyne Pharmaceuticals INC. | $24.56 | 2020 | |
| Sensus Healthcare, INC. | $23.13 | 2024 | |
| Sanofi-Aventis U.S. LLC | $21.29 | 2023 | |
| Prugen, INC. Pharmaceuticals | $16.31 | 2020 | |
| Journey Medical Corporation | $11.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Scheiner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.